Literature DB >> 12893188

Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix.

G Cecilie Alfsen1, Wenche Reed, Vera M Abeler.   

Abstract

OBJECTIVE: Reproducibility of histopathologic classification systems is of major importance for their utility in daily practice and in research. The reproducibility of histologic classification of non-squamous carcinomas (non-SCC) of the uterine cervix was evaluated, using population-based material from two 5-year periods in Norway.
METHODS: Histologic slides from 388 tumors were reviewed by three experienced pathologists and analyzed for inter- and intraobserver agreement on histological subtypes and grade.
RESULTS: Kappa values of inter- and intraobserver agreement were moderate to substantial for all major adenocarcinoma subgroups (endocervical, endometrioid, clear cell, or serous carcinoma), and fair to poor for mixed carcinomas and adenocarcinomas not otherwise specified (NOS). Interobserver agreement on villoglandular and adenosquamous carcinomas was poor, and the distinction of adenocarcinoma in situ from well-differentiated carcinoma proved difficult. Reproducibility of the high-risk subgroups of small cell and undifferentiated carcinomas was acceptable from a statistical point of view (kappa values >0.50). However, the authors agreed upon the diagnosis of small cell carcinomas and undifferentiated carcinomas only in 2/3 of these high-risk diagnoses. Patients with high-risk diagnoses showed significantly lower overall survival than patients with non-high-risk diagnoses (P < 0.001). This inferior survival was independent of whether the reviewers had agreed on the high-risk diagnosis or not.
CONCLUSION: Clinicians should be aware of the potential inconsistencies of histopathologic diagnoses. No histopathological classification system will ever be perfectly reproducible. Future histopathologic classification of the uterine cervix should emphasize the distinction between groups of particularly low or high prognostic risks.

Entities:  

Mesh:

Year:  2003        PMID: 12893188     DOI: 10.1016/s0090-8258(03)00280-4

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

Review 1.  Ovarian metastasis in a transposed ovary 10 years after primary cervical cancer: the importance of histologic examination and review of literature.

Authors:  Julienne A Janse; Daisy M D S Sie-Go; Henk W R Schreuder
Journal:  BMJ Case Rep       Date:  2011-06-17

2.  Villoglandular papillary adenocarcinoma of the uterine cervix: A report of 4 cases and a review of the literature.

Authors:  Qiang-Yong Zhou; Hai-Yan Chen; Si-Meng Yang; Yue-Hua Li; Xue-Qing Wu
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

Review 3.  False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.

Authors:  Anna Macios; Andrzej Nowakowski
Journal:  Diagnostics (Basel)       Date:  2022-06-20

4.  The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix.

Authors:  Sul Lee; Hyun Joo Lee; Kyung Un Choi; Byung Su Kwon; Dong Soo Suh; Dae Hoon Jeong; Geun Joo Kim; Tae Hwa Lee; Hyun-Jin Roh; Ki Hyung Kim
Journal:  J Res Med Sci       Date:  2020-05-22       Impact factor: 1.852

5.  Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.

Authors:  Katsiaryna Holl; Andrzej M Nowakowski; Ned Powell; W Glenn McCluggage; Edyta C Pirog; Sabrina Collas De Souza; Wiebren A Tjalma; Mats Rosenlund; Alison Fiander; Maria Castro Sánchez; Vasileia Damaskou; Elmar A Joura; Benny Kirschner; Robert Koiss; John O'Leary; Wim Quint; Olaf Reich; Aureli Torné; Michael Wells; Lukas Rob; Larisa Kolomiets; Anco Molijn; Alevtina Savicheva; Elena Shipitsyna; Dominique Rosillon; David Jenkins
Journal:  Int J Cancer       Date:  2015-07-14       Impact factor: 7.396

6.  Is it time to call for improvement in surgical techniques for minimally invasive radical hysterectomy?

Authors:  Linus Chuang; Pratistha Koirala; Farr Nezhat
Journal:  JSLS       Date:  2020 Jan-Mar       Impact factor: 2.172

Review 7.  Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.

Authors:  Anna K Dietl; Matthias W Beckmann; Konrad Aumann
Journal:  Arch Gynecol Obstet       Date:  2021-05-25       Impact factor: 2.344

8.  Prognostic value of histopathology and trends in cervical cancer: a SEER population study.

Authors:  Vincent Vinh-Hung; Claire Bourgain; Georges Vlastos; Gábor Cserni; Mark De Ridder; Guy Storme; Anne-Thérèse Vlastos
Journal:  BMC Cancer       Date:  2007-08-23       Impact factor: 4.430

9.  Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination.

Authors:  Jeanne M Pimenta; Claudia Galindo; David Jenkins; Sylvia M Taylor
Journal:  BMC Cancer       Date:  2013-11-21       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.